Saint-Petersburg, Russia

Nickolay V Sinackevich

This inventor holds 1 USPTO granted patent. Top assignee: Cytran, Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nickolay V Sinackevich. Retrieved from https://idiyas.com/inventor/nickolay-v-sinackevich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nickolay V Sinackevich

Introduction

Nickolay V Sinackevich is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the field of pharmacology through his innovative work. His research focuses on immunomodulation and the treatment of pathological neovascular conditions.

Latest Patents

Sinackevich holds a patent for "Analogs of L-Glu-L-Trp having pharmacological activity." This invention provides analogs of L-Glu-L-Trp and methods of using them for immunomodulation. The analogs include the substitution of a carbon atom for a nitrogen atom in the indole ring of tryptophan. This innovative approach has the potential to advance therapeutic options in the medical field.

Career Highlights

Sinackevich is associated with Cytran, Inc., where he continues to develop his research and inventions. His work has garnered attention for its potential applications in treating various medical conditions. He has demonstrated a commitment to advancing scientific knowledge and improving healthcare outcomes.

Collaborations

One of his notable coworkers is Lawrence R Green. Their collaboration reflects a shared dedication to innovation and research in pharmacology.

Conclusion

Nickolay V Sinackevich's contributions to the field of pharmacology through his patent and work at Cytran, Inc. highlight his role as an influential inventor. His innovative approaches have the potential to make a significant impact on medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…